학력 및 경력사항

• 한양대학교 의학전문대학원 졸업

• 2024-현재  | 이대목동병원 소화기내과 진료조교수
• 2022-2024  | 인천세종병원 소화기내과 과장
• 2020-2022  | 서울대학교병원 소화기내과 전임의
• 2017-2020  | 한양대학교병원 전공의
• 2016-2017  | 한양대학교병원 인턴

• 대한간학회 평생회원
• 대한간암학회 평생회원
• 대한소화기내시경학회 평생회원
• 대한소화기학회 정회원
• 대한내과학회 정회원

•  Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis.  BMC Gastroenterol. 2022 Mar 25;22(1):135. 
•  Sericin Peptide Attenuates Non-Alcoholic Steatohepatitis Via Mitochondrial Function Modulation.  ASNH. 2020 Aug 24. doi:10.31080/ASNH.2020.04.0749. 
•  Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation.  Dig Dis Sci. 2022 Oct;67(10):4939-4949. 
•  Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection.  J Nucl Med. 2022 Aug;63(8):1215-1222. 
•  Comparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma.  Clin Gastroenterol Hepatol. 2022 Aug;20(8):1877-1880.e3. 
•  Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral Treatment.  Diagnostics (Basel). 2022 Jul 20;12(7):1757. 
•  Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study.  J Hepatocell Carcinoma. 2021 Dec 7;8:1565-1577. 
•  Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma.  Cancers (Basel). 2021 Nov 29;13(23):6009. 

• [건강이야기] 황달이 의심되나요? 황달의 원인과 예방법 2024-09-09